Morgan Stanley »

Aptevo Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Aptevo Therapeutics (APVO) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Aptevo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aptevo Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aptevo Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $60 194 0.31
2024-03-31 $909 194 4.69